Hemophilia B (or Christmas disease) is less common than hemophilia A and results when the person does not have enough clotting factor IX.Learn more
Search Results173 results found
CSL Behring has therapies for treating Hemophilia A, a bleeding disorder which is caused by deficient or dysfunctional clotting factor VIII. Learn more.
CSL Behring has therapies for treating Hemophilia B, a bleeding disorder which occurs when a person does not have enough clotting factor IX. Learn more.
Obesity rates appear on the rise for people with hemophilia. How can bleeding disorder patients stay healthy?
Pro hockey coach and award-winning actress to receive honors at the National Hemophilia Foundation's 2019 Red Tie Soiree.
Kids who can make cocoa have one of the skills needed to self infuse clotting factor.
CSL Behring conducts clinical trials for breakthrough medicines that treat hemophilia and other rare diseases. See our current clinical trials.
Gettin’ in the Game alum shares tips, inspiration with kids with bleeding disorders.
U.S. family opens their home, and hearts, to a new son who has hemophilia.
Our scientists are recognized for their contributions to developing breakthrough medicines that have the potential to help patients worldwide.
CSL Behring has developed several plasma-derived therapies for treating hereditary bleeding disorders. Learn more.